Works matching IS 13889842 AND DT 2024 AND VI 26 AND IP 3

Results: 29
    1
    2
    3

    The salt paradox in heart failure.

    Published in:
    European Journal of Heart Failure, 2024, v. 26, n. 3, p. 625, doi. 10.1002/ejhf.3194
    By:
    • Cox, Zachary L.;
    • Testani, Jeffrey M.
    Publication type:
    Article
    4
    5
    6
    7
    8
    9

    Prevalence of wild‐type transthyretin amyloidosis in a prospective heart failure cohort with preserved and mildly reduced ejection fraction: Results of the Amylo‐VIP‐HF study.

    Published in:
    European Journal of Heart Failure, 2024, v. 26, n. 3, p. 695, doi. 10.1002/ejhf.3186
    By:
    • Tubben, Alwin;
    • Tingen, Hendrea S.A.;
    • Prakken, Niek H.J.;
    • van Empel, Vanessa P.M.;
    • Gorter, Thomas M.;
    • Meems, Laura M.G.;
    • Manintveld, Olivier C.;
    • Rienstra, Michiel;
    • Tieleman, Robert G.;
    • Glaudemans, Andor W.J.M.;
    • van Veldhuisen, Dirk J.;
    • Slart, Riemer H.J.A.;
    • Nienhuis, Hans L.A.;
    • van der Meer, Peter
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16

    Apoptosis, a useful marker in the management of hot‐phase cardiomyopathy?

    Published in:
    European Journal of Heart Failure, 2024, v. 26, n. 3, p. 590, doi. 10.1002/ejhf.3173
    By:
    • Bassetto, Giulia;
    • Merlo, Marco;
    • Dal Ferro, Matteo;
    • Setti, Martina;
    • Paldino, Alessia;
    • Collesi, Chiara;
    • Artioli, Rebecca;
    • Loffredo, Francesco;
    • D'Elia, Saverio;
    • Golino, Paolo;
    • Fabris, Enrico;
    • Bussani, Rossana;
    • Metra, Marco;
    • Limongelli, Giuseppe;
    • Sinagra, Gianfranco
    Publication type:
    Article
    17
    18
    19

    Role of arrhythmic phenotype in prognostic stratification and management of dilated cardiomyopathy.

    Published in:
    European Journal of Heart Failure, 2024, v. 26, n. 3, p. 581, doi. 10.1002/ejhf.3168
    By:
    • Setti, Martina;
    • Merlo, Marco;
    • Gigli, Marta;
    • Munaretto, Laura;
    • Paldino, Alessia;
    • Stolfo, Davide;
    • Pio Loco, Carola;
    • Medo, Kristen;
    • Gregorio, Caterina;
    • De Luca, Antonio;
    • Graw, Sharon;
    • Castrichini, Matteo;
    • Cannatà, Antonio;
    • Ribichini, Flavio Luciano;
    • Dal Ferro, Matteo;
    • Taylor, Matthew;
    • Sinagra, Gianfranco;
    • Mestroni, Luisa
    Publication type:
    Article
    20

    Blood pressure and intensive treatment up‐titration after acute heart failure hospitalization: Insights from the STRONG‐HF trial.

    Published in:
    European Journal of Heart Failure, 2024, v. 26, n. 3, p. 638, doi. 10.1002/ejhf.3174
    By:
    • Pagnesi, Matteo;
    • Vilamajó, Oscar Alberto Gomez;
    • Meiriño, Alejandro;
    • Dumont, Carlos Alberto;
    • Mebazaa, Alexandre;
    • Davison, Beth;
    • Adamo, Marianna;
    • Arrigo, Mattia;
    • Barros, Marianela;
    • Biegus, Jan;
    • Celutkiene, Jelena;
    • Čerlinskaitė‐Bajorė, Kamilė;
    • Chioncel, Ovidiu;
    • Cohen‐Solal, Alain;
    • Damasceno, Albertino;
    • Diaz, Rafael;
    • Edwards, Christopher;
    • Filippatos, Gerasimos;
    • Gayat, Etienne;
    • Kimmoun, Antoine
    Publication type:
    Article
    21

    The gap between real‐world and guidelines in the use of sodium–glucose cotransporter 2 inhibitors for heart failure patients with reduced ejection fraction: Is it underestimated or overestimated? Letter regarding the article 'Real‐world use of sodium–glucose cotransporter 2 inhibitors in patients with heart failure and reduced ejection fraction: Data from the Swedish Heart Failure Registry'

    Published in:
    European Journal of Heart Failure, 2024, v. 26, n. 3, p. 704, doi. 10.1002/ejhf.3163
    By:
    • Zhao, Yuqin;
    • Sun, Jun;
    • Xie, Cheng
    Publication type:
    Article
    22

    Efficacy and safety of CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: Rationale and design of the HF‐REVERT trial.

    Published in:
    European Journal of Heart Failure, 2024, v. 26, n. 3, p. 674, doi. 10.1002/ejhf.3139
    By:
    • Bauersachs, Johann;
    • Solomon, Scott D.;
    • Anker, Stefan D.;
    • Antorrena‐Miranda, Isabel;
    • Batkai, Sandor;
    • Viereck, Janika;
    • Rump, Steffen;
    • Filippatos, Gerasimos;
    • Granzer, Ulrich;
    • Ponikowski, Piotr;
    • de Boer, Rudolf A.;
    • Vardeny, Orly;
    • Hauke, Wilfried;
    • Thum, Thomas
    Publication type:
    Article
    23

    Myocardial perfusion in cardiac amyloidosis.

    Published in:
    European Journal of Heart Failure, 2024, v. 26, n. 3, p. 598, doi. 10.1002/ejhf.3137
    By:
    • Chacko, Liza;
    • Kotecha, Tushar;
    • Ioannou, Adam;
    • Patel, Niket;
    • Martinez‐Naharro, Ana;
    • Razvi, Yousuf;
    • Patel, Rishi;
    • Massa, Paolo;
    • Venneri, Lucia;
    • Brown, James;
    • Porcari, Aldostefano;
    • Knott, Kristopher;
    • Manisty, Charlotte;
    • Knight, Daniel;
    • Lockie, Tim;
    • Rakhit, Roby;
    • Lachmann, Helen;
    • Wechelakar, Ashutosh;
    • Whelan, Carol;
    • Ponticos, Markella
    Publication type:
    Article
    24
    25
    26

    Issue Information.

    Published in:
    European Journal of Heart Failure, 2024, v. 26, n. 3, p. i, doi. 10.1002/ejhf.3181
    Publication type:
    Article
    27
    28
    29